CAMMX
Price
$20.05
Change
+$0.06 (+0.30%)
Updated
Aug 11 closing price
Net Assets
39.63M
VEXAX
Price
$187.48
Change
+$0.60 (+0.32%)
Updated
Aug 11 closing price
Net Assets
93.63B
Interact to see
Advertisement

CAMMX vs VEXAX

CAMMX vs VEXAX Comparison Chart in %
View a ticker or compare two or three
VS
CAMMX vs. VEXAX commentary
Aug 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAMMX is a StrongBuy and VEXAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 93.6B vs. CAMMX (39.6M). CAMMX pays higher dividends than VEXAX: CAMMX (1.14) vs VEXAX (1.03). CAMMX was incepted earlier than VEXAX: CAMMX (15 years) vs VEXAX (26 years). CAMMX (1.19) is less costly to investors than VEXAX (0.05). CAMMX is a more actively managed with annual turnover of: 47.00 vs. VEXAX (12.00). CAMMX has a lower initial minimum investment than VEXAX: CAMMX (2500) vs VEXAX (3000). VEXAX annual gain was more profitable for investors over the last year : 26.06 vs. CAMMX (-6.53). VEXAX return over 5 years is better than : 32.85 vs. CAMMX (-17.96).
CAMMXVEXAXCAMMX / VEXAX
Total Expense Ratio0.950.051,900%
Annual Report Gross Expense Ratio1.190.052,380%
Fund Existence15 years26 years-
Gain YTD19.48617.999108%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets39.6M93.6B0%
Annual Yield % from dividends1.141.03110%
Returns for 1 year-6.5326.06-25%
Returns for 3 years-9.9065.03-15%
Returns for 5 years-17.9632.85-55%
Returns for 10 years60.30182.6533%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTIEX17.13N/A
N/A
Fidelity Total International Equity
FQUAX20.22N/A
N/A
AMG River Road Large Cap Value Select N
SAPCX35.60N/A
N/A
ClearBridge Appreciation C
RTDCX15.17N/A
N/A
Russell Inv Multifactor US Equity C
BIVIX18.48N/A
N/A
Invenomic Institutional